Apyx Medical Corporation Common Stock (NASDAQ: APYX)
Company Name:Apyx Medical Corporation Common Stock
Stock Symbol:NASDAQ: APYX
Class Period Start:12/21/2018
Class Period End (inclusive):04/01/2019
Filing Deadline:06/16/2019
According to the Complaint, APYX Medical Corporation is a medical technology company that purportedly develops J-Plasma, a plasma-based surgical product for cutting, coagulation and ablation of soft tissue. The Company markets and sells J-Plasma under the brand name Renuvion Cosmetic Technology. The Company claims that it has developed J-Plasma/Renuvion for use in dermal resurfacing procedures. Apyx was formerly known as Bovie Medical Corporation, and its stock traded on the New York Stock Exchange (“NYSE”) under the symbol “BVX” until January 1, 2019.